查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1797971

2032 年妇科机器人手术市场预测：按组件、手术类型、应用、最终用户和地区进行的全球分析

Gynecology Robotic Surgery Market Forecasts to 2032 - Global Analysis By Component (Robotic Surgical Systems, Instruments & Accessories and Services & Maintenance), Procedure Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球妇科机器人手术市场预计在 2025 年达到 48 亿美元，到 2032 年将达到 113 亿美元，预测期内的复合年增长率为 12.9%。

妇科机器人手术是一种技术先进的微创手术方法，利用机器人系统辅助执行复杂的妇科手术，提高手术的精确度和控制力。外科医师透过主机控制机械臂，将手部运动转化为患者体内精密的器材运动。此技术常用于子宫切除术、子宫肌瘤切除术和子宫内膜异位症治疗。其优点包括减少失血、缩小切口、加快恢復速度以及提高手术可视性，使其成为精细、高精度妇科手术的首选。

《机器人手术杂誌》发表的一篇文献回顾发现，在分析的 838 篇关于妇产科机器人手术的文章中，41.1% 集中在妇科肿瘤，其次是良性妇科肿瘤（21.0%）和泌尿妇科肿瘤（18.6%）。

微创手术日益受到偏好

患者越来越渴望手术能够实现更小的切口、更少的失血、更少的术后疼痛以及更快的恢復正常活动。机器人系统完美契合这些愿望，它为外科医生提供了更高的灵活性、手术区域的高清3D视觉化以及比传统腹腔镜更大的运动范围。这使得他们能够以惊人的精确度执行复杂而精细的手术，最终改善病患的预后，缩短住院时间，降低再入院率。

临床优势和报销不确定性

虽然机器人系统与开放性手术相比具有明显的优势，但一些研究表明，对于某些手术，机器人手术的患者治疗效果与传统腹腔镜手术相当。这种不确定性，加上机器人手术显着更高的成本，使得医院难以证明其投资的合理性。此外，保险公司的报销政策并不总是一致或有利的，机器人手术的报销率通常与费用较低的腹腔镜手术相同。这种财务差异阻碍因素了医疗机构投资和使用这些先进系统的积极性，从而严重抑制了市场成长。

扩展到门诊手术中心 (ASC) 和新应用

随着机器人系统变得越来越紧凑和经济高效，它们正成为门诊病人的可行选择，为患者提供更便利、通常更经济实惠的选择。在辅助生殖中心 (ASC) 执行复杂手术的能力可以增加患者数量，并带来更方便的患者体验。新型仪器和软体的开发正在为治疗深部浸润性子宫内膜异位症、骨盆器官脱垂以及晚期妇科癌症等复杂疾病铺平道路，而这些疾病此前无法透过机器人干预治疗。向新临床领域的扩展为市场中的公司带来了重要的创新和成长机会。

监管障碍和冗长的核准流程

像FDA这样的监管机构需要大量的临床数据和检验，以确保新型机器人系统及相关设备的安全性和有效性。这项严格的流程可能会减缓新技术的市场准入，限制竞争，并对创新构成重大障碍。由于开发人员需要进行耗时且昂贵的临床试验来证明其设备的优势，这可能会阻碍中小型公司进入市场，并减缓技术发展的步伐。

COVID-19的影响：

新冠疫情对妇科机器人手术市场产生了双重影响。在疫情初期，由于医院资源和人员被重新分配用于救治新冠患者，择期手术和非必要手术被推迟或取消，市场经历了大幅下滑。这导致新的机器人系统部署暂时停止，手术量下降，对主要市场参与者的收益造成了不利影响。然而，随着医疗体系的调整，疫情也凸显了机器人手术的独特优势。

机器人手术系统市场预计将成为预测期内最大的市场

机器人手术系统领域预计将在预测期内占据最大的市场占有率，因为它是机器人手术的核心和最重要的组成部分。机器人手术系统是其技术核心，包含先进的可视化、仪器和控制机制，使市场占有率能够以无与伦比的精度执行复杂的手术。

预计预测期内，肌瘤摘除领域复合年增长率最高

预计子宫肌瘤切除术领域将在预测期内实现最高增长率，这得益于子宫肌瘤患病率的不断上升以及机器人辅助子宫肌瘤切除术已被证实的益处。子宫肌瘤是一种常见疾病，影响许多女性，而机器人手术为切除子宫肌瘤提供了一种微创解决方案。机器人系统卓越的灵活性和3D视觉化技术对此类手术尤其有利，使外科医生能够精确地消融和切除肌瘤，同时细緻地保留子宫组织。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场占有率，这得益于一系列有利的经济和人口因素。该地区人口数量庞大且老化速度迅速，导致需要手术介入的妇科疾病发生率不断上升。这项人口结构变化与中国、日本和印度等主要经济体的显着经济成长相吻合，并由此带来了医疗支出的成长。此外，该地区各国政府正在大力投资医疗基础设施的现代化，并促进先进医疗技术的采用。

复合年增长率最高的地区：

预计亚太地区将在预测期内实现最高的复合年增长率，这得益于医疗保健投资的增加、患者人数的不断增长以及技术应用的强劲推动力。亚洲主要国家可支配收入的不断增长，正推动患者和医疗保健提供者对机器人手术等高端医疗解决方案的投资兴趣。该地区也正在成为医疗旅游的中心，这使得领先的机器人手术系统製造商纷纷在当地设立办事处和培训中心，以支持其市场扩张。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球妇科机器人手术市场（按组件）

  • 机器人手术系统
    • 多臂机器人平台
    • 单埠机器人系统
    • 模组化机器人系统
    • 远端手术系统
    • 混合系统
  • 设备和配件
    • 内视镜器械
    • 能源设备
    • 相机和视觉化工具
    • 免洗配件
    • 设备追踪和校准工具
  • 服务和维护
    • 安装和设定服务
    • 预防性保养
    • 修正性维护
    • 培训和认证
    • 远端监控和支援

6. 全球妇科机器人手术市场（依手术类型）

  • 子宫切除术
  • 子宫肌瘤切除术
  • 卵巢
  • 骶骨阴道固定术
  • 子宫内膜异位症切除术
  • 输卵管吻合术
  • 其他类型的手术

7. 全球妇科机器人手术市场（依应用）

  • 子宫肌瘤
  • 子宫癌
  • 子宫内膜异位症
  • 卵巢囊肿
  • 骨盆器官脱垂
  • 其他用途

8. 全球妇科机器人手术市场（依最终用户）

  • 医院和诊所
  • 门诊手术中心
  • 医生诊所
  • 专科妇科中心
  • 其他最终用户

9. 全球妇科机器人手术市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要发展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Intuitive Surgical Inc
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc
  • Globus Medical Inc
  • CMR Surgical Ltd
  • Titan Medical Inc
  • Asensus Surgical Inc
  • Smith & Nephew plc
  • Renishaw plc
  • Johnson & Johnson
  • Siemens Healthineers
  • GE Healthcare
  • Olympus Corporation
  • Boston Scientific Corporation
  • Karl Storz SE & Co. KG
  • B. Braun Melsungen AG
  • Medrobotics Corporation
  • TransEnterix Inc
Product Code: SMRC30341

According to Stratistics MRC, the Global Gynecology Robotic Surgery Market is accounted for $4.8 billion in 2025 and is expected to reach $11.3 billion by 2032 growing at a CAGR of 12.9% during the forecast period. Gynecology robotic surgery is a technologically advanced, minimally invasive surgical approach that utilizes robotic systems to assist in performing complex gynecological procedures with enhanced precision and control. Surgeons operate robotic arms via a console, translating hand movements into refined instrument actions within the patient's body. This technique is commonly used for hysterectomies, myomectomies, and endometriosis treatment. It offers benefits such as reduced blood loss, smaller incisions, faster recovery, and improved visualization, making it a preferred option for delicate and high-precision gynecologic interventions

According to a bibliometric study published in the Journal of Robotic Surgery, out of 838 analyzed publications on robotic surgery in obstetrics and gynecology, 41.1% focused on gynecologic oncology, followed by 21.0% on benign gynecology and 18.6% on urogynecology.

Market Dynamics:

Driver:

Growing preference for minimally invasive surgery

Patients are increasingly seeking out surgeries that result in smaller incisions, reduced blood loss, less postoperative pain, and a faster return to normal life. Robotic systems are perfectly aligned with these desires, offering surgeons enhanced dexterity, a high-definition 3D visualization of the surgical field, and a greater range of motion compared to traditional laparoscopy. This allows for the performance of complex and delicate procedures with remarkable precision, which in turn leads to superior patient outcomes, shorter hospital stays, and lower readmission rates.

Restraint:

Uncertainty in clinical superiority and reimbursement

While robotic systems offer clear advantages over open surgery, some studies have shown that for certain procedures, the patient outcomes with robotic surgery are comparable to those achieved with traditional laparoscopy. This uncertainty, combined with the significantly higher costs associated with robotic procedures, can make it difficult for hospitals to justify the investment. Furthermore, reimbursement policies from insurance providers are not always consistent or favorable, often reimbursing robotic procedures at the same rate as less expensive laparoscopic methods. This financial discrepancy creates a disincentive for healthcare facilities to invest in and utilize these advanced systems, acting as a major restraint on market growth.

Opportunity:

Expansion into ambulatory surgical centers (ASCs) & new applications

As robotic systems become more compact and cost-effective, they are becoming a viable option for outpatient settings, which offer a more convenient and often more affordable option for patients. The ability to perform complex procedures in an ASC can lead to increased patient volume and a more streamlined patient experience. The development of new instruments and software is opening doors for treating complex conditions such as deep infiltrating endometriosis, pelvic organ prolapse, and advanced gynecologic cancers, which previously were not ideal for robotic intervention. This expansion into new clinical areas presents a substantial opportunity for market players to innovate and grow.

Threat:

Regulatory hurdles and lengthy approval processes

Regulatory bodies like the FDA require extensive clinical data and validation to ensure the safety and efficacy of new robotic systems and their associated instruments. This rigorous process can be a major impediment to innovation, delaying the market entry of new technologies and limiting competition. The need for manufacturers to conduct time-consuming and expensive clinical trials to demonstrate the benefits of their devices can discourage smaller companies from entering the market and slow down the pace of technological development.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the gynecology robotic surgery market. In the initial phase of the pandemic, the market experienced a significant downturn as elective and non-essential surgeries were postponed or canceled to reallocate hospital resources and personnel to the care of COVID-19 patients. This resulted in a temporary halt in new robotic system installations and a decline in procedure volumes, which negatively affected the revenue of key market players. However, as the healthcare system adapted, the pandemic also highlighted the unique advantages of robotic surgery.

The robotic surgical systems segment is expected to be the largest during the forecast period

The robotic surgical systems segment is expected to account for the largest market share during the forecast period attributed to its position as the central and most critical component of robotic surgery. The initial high cost of acquiring these sophisticated platforms, along with their associated installation expenses, makes them the largest contributor to market value. These systems are the technological core, housing the advanced visualization, instrumentation, and control mechanisms that enable a surgeon to perform complex procedures with unparalleled precision.

The myomectomy segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the myomectomy segment is predicted to witness the highest growth rate driven by the increasing prevalence of uterine fibroids and the proven benefits of robotic-assisted myomectomy. Uterine fibroids are a common condition affecting many women, and robotic surgery offers a minimally invasive solution for their removal. The exceptional dexterity and 3D visualization provided by robotic systems are particularly beneficial for this procedure, enabling surgeons to precisely dissect and remove fibroids while meticulously preserving the uterine tissue.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to a confluence of favorable economic and demographic factors. The region is home to a vast and rapidly aging population, which is leading to an increased incidence of gynecological conditions requiring surgical intervention. This demographic shift is coinciding with significant economic growth and a corresponding rise in healthcare spending across key countries like China, Japan, and India. Additionally, governments in the region are making substantial investments in modernizing their healthcare infrastructure and promoting the adoption of advanced medical technologies.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by a combination of increasing healthcare investments, a growing patient population, and a strong drive for technological adoption. As disposable incomes rise in key Asian economies, there is a greater willingness among both patients and healthcare providers to invest in premium healthcare solutions like robotic surgery. The region is also becoming a hub for medical tourism and a target for leading robotic surgical system manufacturers, who are establishing local offices and training centers to support market expansion.

Key players in the market

Some of the key players in Gynecology Robotic Surgery Market include Intuitive Surgical Inc, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Globus Medical Inc, CMR Surgical Ltd, Titan Medical Inc, Asensus Surgical Inc, Smith & Nephew plc, Renishaw plc, Johnson & Johnson, Siemens Healthineers, GE Healthcare, Olympus Corporation, Boston Scientific Corporation, Karl Storz SE & Co. KG, B. Braun Melsungen AG, Medrobotics Corporation, and TransEnterix Inc.

Key Developments:

In July 2025, Intuitive Surgical, Inc. receives CE mark for Europe. The latest-generation da Vinci 5 secured CE clearance in July 2025, enabling use in adult and pediatric minimally invasive procedures including gynecology across Europe. The system features force-feedback technology, immersive 3D vision, and streamlined surgeon workflow.

In April 2025, Medtronic plc Submits Hugo(TM) robotic-assisted surgery system to FDA for urologic indication. The Hugo(TM) system achieved primary safety and efficacy endpoints in its Expand URO clinical trial, paving the way for broader U.S. regulatory submissions and anticipated gynecology indications.

Components Covered:

  • Robotic Surgical Systems
  • Instruments & Accessories
  • Services & Maintenance

Procedure Types Covered:

  • Hysterectomy
  • Myomectomy
  • Oophorectomy
  • Sacrocolpopexy
  • Endometriosis Resection
  • Tubal Re-anastomosis
  • Other Procedure Types

Applications Covered:

  • Uterine Fibroids
  • Uterine Cancer
  • Endometriosis
  • Ovarian Cysts
  • Pelvic Organ Prolapse
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Physician Offices
  • Specialty Gynecology Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gynecology Robotic Surgery Market, By Component

  • 5.1 Introduction
  • 5.2 Robotic Surgical Systems
    • 5.2.1 Multi-arm Robotic Platforms
    • 5.2.2 Single-port Robotic Systems
    • 5.2.3 Modular Robotic Systems
    • 5.2.4 Telesurgical Systems
    • 5.2.5 Hybrid Systems
  • 5.3 Instruments & Accessories
    • 5.3.1 Endoscopic Instruments
    • 5.3.2 Energy Devices
    • 5.3.3 Camera & Visualization Tools
    • 5.3.4 Disposable Accessories
    • 5.3.5 Instrument Tracking & Calibration Tools
  • 5.4 Services & Maintenance
    • 5.4.1 Installation & Setup Services
    • 5.4.2 Preventive Maintenance
    • 5.4.3 Corrective Maintenance
    • 5.4.4 Training & Certification
    • 5.4.5 Remote Monitoring & Support

6 Global Gynecology Robotic Surgery Market, By Procedure Type

  • 6.1 Introduction
  • 6.2 Hysterectomy
  • 6.3 Myomectomy
  • 6.4 Oophorectomy
  • 6.5 Sacrocolpopexy
  • 6.6 Endometriosis Resection
  • 6.7 Tubal Re-anastomosis
  • 6.8 Other Procedure Types

7 Global Gynecology Robotic Surgery Market, By Application

  • 7.1 Introduction
  • 7.2 Uterine Fibroids
  • 7.3 Uterine Cancer
  • 7.4 Endometriosis
  • 7.5 Ovarian Cysts
  • 7.6 Pelvic Organ Prolapse
  • 7.7 Other Applications

8 Global Gynecology Robotic Surgery Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Physician Offices
  • 8.5 Specialty Gynecology Centers
  • 8.6 Other End Users

9 Global Gynecology Robotic Surgery Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Intuitive Surgical Inc
  • 11.2 Medtronic plc
  • 11.3 Stryker Corporation
  • 11.4 Zimmer Biomet Holdings Inc
  • 11.5 Globus Medical Inc
  • 11.6 CMR Surgical Ltd
  • 11.7 Titan Medical Inc
  • 11.8 Asensus Surgical Inc
  • 11.9 Smith & Nephew plc
  • 11.10 Renishaw plc
  • 11.11 Johnson & Johnson
  • 11.12 Siemens Healthineers
  • 11.13 GE Healthcare
  • 11.14 Olympus Corporation
  • 11.15 Boston Scientific Corporation
  • 11.16 Karl Storz SE & Co. KG
  • 11.17 B. Braun Melsungen AG
  • 11.18 Medrobotics Corporation
  • 11.19 TransEnterix Inc

List of Tables

  • Table 1 Global Gynecology Robotic Surgery Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gynecology Robotic Surgery Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Gynecology Robotic Surgery Market Outlook, By Robotic Surgical Systems (2024-2032) ($MN)
  • Table 4 Global Gynecology Robotic Surgery Market Outlook, By Multi-arm Robotic Platforms (2024-2032) ($MN)
  • Table 5 Global Gynecology Robotic Surgery Market Outlook, By Single-port Robotic Systems (2024-2032) ($MN)
  • Table 6 Global Gynecology Robotic Surgery Market Outlook, By Modular Robotic Systems (2024-2032) ($MN)
  • Table 7 Global Gynecology Robotic Surgery Market Outlook, By Telesurgical Systems (2024-2032) ($MN)
  • Table 8 Global Gynecology Robotic Surgery Market Outlook, By Hybrid Systems (2024-2032) ($MN)
  • Table 9 Global Gynecology Robotic Surgery Market Outlook, By Instruments & Accessories (2024-2032) ($MN)
  • Table 10 Global Gynecology Robotic Surgery Market Outlook, By Endoscopic Instruments (2024-2032) ($MN)
  • Table 11 Global Gynecology Robotic Surgery Market Outlook, By Energy Devices (2024-2032) ($MN)
  • Table 12 Global Gynecology Robotic Surgery Market Outlook, By Camera & Visualization Tools (2024-2032) ($MN)
  • Table 13 Global Gynecology Robotic Surgery Market Outlook, By Disposable Accessories (2024-2032) ($MN)
  • Table 14 Global Gynecology Robotic Surgery Market Outlook, By Instrument Tracking & Calibration Tools (2024-2032) ($MN)
  • Table 15 Global Gynecology Robotic Surgery Market Outlook, By Services & Maintenance (2024-2032) ($MN)
  • Table 16 Global Gynecology Robotic Surgery Market Outlook, By Installation & Setup Services (2024-2032) ($MN)
  • Table 17 Global Gynecology Robotic Surgery Market Outlook, By Preventive Maintenance (2024-2032) ($MN)
  • Table 18 Global Gynecology Robotic Surgery Market Outlook, By Corrective Maintenance (2024-2032) ($MN)
  • Table 19 Global Gynecology Robotic Surgery Market Outlook, By Training & Certification (2024-2032) ($MN)
  • Table 20 Global Gynecology Robotic Surgery Market Outlook, By Remote Monitoring & Support (2024-2032) ($MN)
  • Table 21 Global Gynecology Robotic Surgery Market Outlook, By Procedure Type (2024-2032) ($MN)
  • Table 22 Global Gynecology Robotic Surgery Market Outlook, By Hysterectomy (2024-2032) ($MN)
  • Table 23 Global Gynecology Robotic Surgery Market Outlook, By Myomectomy (2024-2032) ($MN)
  • Table 24 Global Gynecology Robotic Surgery Market Outlook, By Oophorectomy (2024-2032) ($MN)
  • Table 25 Global Gynecology Robotic Surgery Market Outlook, By Sacrocolpopexy (2024-2032) ($MN)
  • Table 26 Global Gynecology Robotic Surgery Market Outlook, By Endometriosis Resection (2024-2032) ($MN)
  • Table 27 Global Gynecology Robotic Surgery Market Outlook, By Tubal Re-anastomosis (2024-2032) ($MN)
  • Table 28 Global Gynecology Robotic Surgery Market Outlook, By Other Procedure Types (2024-2032) ($MN)
  • Table 29 Global Gynecology Robotic Surgery Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Gynecology Robotic Surgery Market Outlook, By Uterine Fibroids (2024-2032) ($MN)
  • Table 31 Global Gynecology Robotic Surgery Market Outlook, By Uterine Cancer (2024-2032) ($MN)
  • Table 32 Global Gynecology Robotic Surgery Market Outlook, By Endometriosis (2024-2032) ($MN)
  • Table 33 Global Gynecology Robotic Surgery Market Outlook, By Ovarian Cysts (2024-2032) ($MN)
  • Table 34 Global Gynecology Robotic Surgery Market Outlook, By Pelvic Organ Prolapse (2024-2032) ($MN)
  • Table 35 Global Gynecology Robotic Surgery Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 36 Global Gynecology Robotic Surgery Market Outlook, By End User (2024-2032) ($MN)
  • Table 37 Global Gynecology Robotic Surgery Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 38 Global Gynecology Robotic Surgery Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 39 Global Gynecology Robotic Surgery Market Outlook, By Physician Offices (2024-2032) ($MN)
  • Table 40 Global Gynecology Robotic Surgery Market Outlook, By Specialty Gynecology Centers (2024-2032) ($MN)
  • Table 41 Global Gynecology Robotic Surgery Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.